Significance and case analysis of FMR1 mutation screening during early and middle pregnancy.
10.3760/cma.j.cn511374-20200319-00181
- Author:
Qinying CAO
1
;
Weihong MU
;
Donglan SUN
;
Junzhen ZHU
;
Jun GE
;
Yuanyuan PENG
;
Jing ZHANG
Author Information
1. The Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei 050011, China. zjhbmu@163.com.
- Publication Type:Journal Article
- MeSH:
DNA Copy Number Variations;
Female;
Fragile X Mental Retardation Protein/genetics*;
Fragile X Syndrome/genetics*;
Genetic Counseling;
Humans;
Mutation;
Pregnancy;
Trinucleotide Repeat Expansion;
Trinucleotide Repeats
- From:
Chinese Journal of Medical Genetics
2021;38(5):450-453
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To screen for mutations of fragile X mental retardation 1 (FMR1) gene during early and middle pregnancy and provide prenatal diagnosis for those carrying high-risk CGG trinucleotide expansions.
METHODS:Peripheral blood samples of 2316 pregnant women at 12 to 21(+6) gestational weeks were collected for the extraction of genomic DNA. CGG repeats of the FMR1 gene were detected by fluorescence PCR and capillary electrophoresis. Genetic counseling and prenatal diagnosis were provided for 3 women carrying the premutations.
RESULTS:The carrier rate of CGG repeats of the FMR1 gene was 1 in 178 for the intermediate type and 1 in 772 for the premutation types. The highest frequency allele of CGG was 29 repeats, which accounted for 49.29%, followed by 30 repeats (28.56%) and 36 repeats (8.83%). In case 1, the fetus had a karyotype of 45,X, in addition with premutation type of CGG expansion of the FMR1 gene. Following genetic counseling, the couple chose to terminate the pregnancy through induced labor. The numbers of CGG repeats were respectively 70/- and 29/30 for the husband and wife. In case 2, amniocentesis was performed at 20 weeks of gestation. The number of CGG repeats of the FMR1 gene was 29/-. No abnormality was found in the fetal karyotype and chromosomal copy number variations. The couple chose to continue with the pregnancy. Case 3 refused prenatal diagnosis after genetic counseling and gave birth to a girl at full term, who had a birth weight of 2440 g and no obvious abnormality found during follow-up.
CONCLUSION:Pregnant women should be screened for FMR1 gene mutations during early and middle pregnancy, and those with high-risk CGG expansions should undergo prenatal diagnosis, genetic counseling and family study.
